(Q46882251)

English

Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category

scientific article published in March 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16396768

Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16396768

immunohistochemistry

1 reference

based on heuristic

inferred from title

author name string

Friedrich Wimazal

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16396768

Maria-Theresa Krauth

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16396768

Anja Vales

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16396768

Alexandra Böhm

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16396768

Hermine Agis

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16396768

Karoline Sonneck

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16396768

Karl J Aichberger

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16396768

Matthias Mayerhofer

8

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16396768

Ingrid Simonitsch-Klupp

9

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16396768

Leonhard Müllauer

10

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16396768

Wolfgang R Sperr

11

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16396768

Peter Valent

12

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16396768

publication date

1 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16396768

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16396768

47

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16396768

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16396768

451-460

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16396768

Proposals for the classification of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1080%2F10428190500353083

21 January 2018

The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group

1 reference

https://api.crossref.org/works/10.1080%2F10428190500353083

21 January 2018

Apoptosis and its role in the myelodysplastic syndromes: implications for disease natural history and treatment

1 reference

https://api.crossref.org/works/10.1080%2F10428190500353083

21 January 2018

The role of apoptosis in the pathogenesis of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1080%2F10428190500353083

21 January 2018

Angiogenesis in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1080%2F10428190500353083

21 January 2018

Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1080%2F10428190500353083

21 January 2018

Increased angiogenesis in the bone marrow of patients with systemic mastocytosis.

1 reference

https://api.crossref.org/works/10.1080%2F10428190500353083

21 January 2018

BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin.

1 reference

https://api.crossref.org/works/10.1080%2F10428190500353083

21 January 2018

p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts

1 reference

https://api.crossref.org/works/10.1080%2F10428190500353083

21 January 2018

Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants.

1 reference

https://api.crossref.org/works/10.1080%2F10428190500353083

21 January 2018

Expression of angiogenic factors in chronic myeloid leukaemia: role of the bcr/abl oncogene, biochemical mechanisms, and potential clinical implications

1 reference

https://api.crossref.org/works/10.1080%2F10428190500353083

21 January 2018

Smoldering acute leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190500353083

21 January 2018

Human preleukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190500353083

21 January 2018

Biological significance of proliferation, apoptosis, cytokines, and monocyte/macrophage cells in bone marrow biopsies of 145 patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1080%2F10428190500353083

21 January 2018

Blast colony forming cell-binding capacity of bone marrow stroma from myelodysplastic patients

1 reference

https://api.crossref.org/works/10.1080%2F10428190500353083

21 January 2018

Bone marrow stroma from refractory anemia of myelodysplastic syndrome is defective in its ability to support normal CD34-positive cell proliferation and differentiation in vitro

1 reference

https://api.crossref.org/works/10.1080%2F10428190500353083

21 January 2018

Significance of angiogenin plasma concentrations in patients with acute myeloid leukaemia and advanced myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1080%2F10428190500353083

21 January 2018

Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190500353083

21 January 2018

Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1080%2F10428190500353083

21 January 2018

Reference standards for bone marrow cellularity

1 reference

https://api.crossref.org/works/10.1080%2F10428190500353083

21 January 2018

Identifiers

10.1080/10428190500353083

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16396768

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16396768

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46882251&oldid=2166066377"